jazzpharmaceuticals
Charlotte’s Web is the largest U.S. publicly traded pure play on CBD.Cresco Labs is a diversified integrated cannabis company and a leading multistate operator.Jazz Pharmaceuticals and its subsidiary have the only FDA-approved CBD drug on the market.The CBD industry has faced its share of hurdles but one thing is clear: It is here to stay and should grow at a high double-digit compound annual growth rate (CAGR) for the next six years or more. As of 2021, the CBD industry was valued at just over $12.8 billion and is expected to grow at a 20% CAGR through 2028. That’s a gain of 250% over the nex...
ValueWalk
In late June, Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) began to market a drug aimed at treating people whose metastatic small cell lung cancer has not responded to an initial round of chemotherapy. Q4 2020 hedge fund letters, conferences and more The drug, lurbinectedin, was developed by Madrid-based PharmaMar S.A., which in December 2019 signed a licensing agreement with Jazz. This permitted Jazz to sell the drug in the United States under the brand name Zepzelca. (Lurbinectedin had failed a clinical trial for ovarian cancer in 2018.) Dublin-based Jazz, with its shares listed on the Nasdaq, has...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら